Latest News about Benzinga
Recent news which mentions Benzinga
A Closer Look at Schlumberger's Options Market Dynamics
September 25, 2024
Tickers
SLB
From Benzinga
Sam Altman's Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA
September 25, 2024
From Benzinga
What's Going On With Chinese EV Maker XPeng Stock Wednesday?
September 25, 2024
From Benzinga
Cipher Mining Shares Continue To Climb: What's Going On With Bitcoin Mining Stocks Wednesday?
September 25, 2024
From Benzinga
EXCLUSIVE: Alphabet, AerCap, First Citizens: Asset Manager's Trio Of Post-Earnings Bets
September 25, 2024
From Benzinga
Price Over Earnings Overview: Vipshop Holdings
September 25, 2024
From Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today
September 25, 2024
From Benzinga
From Benzinga
Cannabis Licensing And Finding Dispensaries In New York Just Got Easier—Here's How
September 25, 2024
Tickers
NEWS
From Benzinga
Yuanbao Drives Business With Technology-Driven Insurance Services In Tough Market
September 25, 2024
From Benzinga
'Investors Are Looking Beyond The Hype': What's Driving Cannabis Investments Today?
September 25, 2024
Tickers
CCC
From Benzinga
Looking At Marvell Tech's Recent Unusual Options Activity
September 25, 2024
Tickers
MRVL
From Benzinga
Marjorie Taylor Greene Stays Loyal To Trump, Keeps DJT Stock, Buys Into Warren Buffett's Berkshire In Latest Trades
September 25, 2024
From Benzinga
Bitcoin's Price Rally Could Be Driven By Multiple Factors In Coming Months: Standard Chartered
September 25, 2024
From Benzinga
10 Financials Stocks Whale Activity In Today's Session
September 25, 2024
From Benzinga
10 Consumer Discretionary Stocks With Whale Alerts In Today's Session
September 25, 2024
From Benzinga
10 Information Technology Stocks Whale Activity In Today's Session
September 25, 2024
From Benzinga
Exxon Mobil Options Trading: A Deep Dive into Market Sentiment
September 25, 2024
Tickers
XOM
From Benzinga
Accenture Options Trading: A Deep Dive into Market Sentiment
September 25, 2024
Tickers
ACN
From Benzinga
From Benzinga
From Benzinga
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
September 25, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.